Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes

@article{Khan2015AcquiredGA,
  title={Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes},
  author={F. H. Khan and V. Pandian and S. Ramraj and M. Natarajan and S. Aravindan and T. Herman and N. Aravindan},
  journal={BMC Cancer},
  year={2015},
  volume={15}
}
BackgroundDetermining the driving factors and molecular flow-through that define the switch from favorable to aggressive high-risk disease is critical to the betterment of neuroblastoma cure.MethodsIn this study, we examined the cytogenetic and tumorigenic physiognomies of distinct population of metastatic site- derived aggressive cells (MSDACs) from high-risk tumors, and showed the influence of acquired genetic rearrangements on poor patient outcomes.ResultsKaryotyping in SH-SY5Y and MSDACs… Expand
RD3 loss dictates high-risk aggressive neuroblastoma and poor clinical outcomes
TLDR
The loss of RD3 in high-risk neuroblastoma, its novel, thus-far unrecognized metastasis suppressor function, and further imply that RD3-loss may directly relate to tumor aggressiveness and poor clinical outcomes are demonstrated. Expand
Implementation of Novel Mode for Evaluation of MYCN Amplification that can Predict Outcome in Patients with Neuroblastoma
TLDR
FISH is proved to be rapid, sensitive, and reliable method for detection of MYCN oncogene amplification in routinely processed samples and confirmed that patients with both chromosomal changes and significant MYCN amplification are characterized with aggressive clinical course. Expand
Characterization of Chromosomal Aberrationsin Neuroblastoma Formalin-Fixed Paraffin-Embedded Specimens with StandardArrayCGH Procedure - Preliminary Experience
TLDR
This report focuses on a possibility to use standard microarray procedure to demonstrate critical structural chromosomal alteration in archival samples of NB tumors and demonstrates that it is possible to obtain reliable and highquality microarray data fromarchival samples. Expand
De novo regulation of RD3 synthesis in residual neuroblastoma cells after intensive multi-modal clinical therapy harmonizes disease evolution
TLDR
Whether RD3 loss is an acquired process in cells that survive intensive multi-modal clinical therapy (IMCT) and its significance in disease evolution is investigated and profound reductions in RD3 transcription indicate the de novo regulation of RD3 synthesis in resistant cells after IMCT. Expand
The Clinical Significance and Potential Molecular Mechanism of PTTG1 in Esophageal Squamous Cell Carcinoma
  • Shang-Wei Chen, Hua-Fu Zhou, +14 authors Gang Chen
  • Medicine
  • Frontiers in Genetics
  • 2020
TLDR
The high expression of PTTG1 may play an important role in the formation of ESCC by regulating the downstream target genes SLC25A17 and ERH, and it was observed that PTTg1 may interact with these genes through chemokines and cytokine signaling pathways. Expand
Significance of hematopoietic surface antigen CD34 in neuroblastoma prognosis and the genetic landscape of CD34-expressing neuroblastoma CSCs.
TLDR
While the function of CD34 in NB evolution requires further in-depth investigation, careful consideration should be exercised for autologous stem cell rescue with CD34+ selection in NB patients. Expand
Splicing-sensitive fusion transcripts associated with key tumor characteristics occur at high frequency in neuroblastoma
TLDR
The ZNF451-BAG2 fusion is characterized, which generates a truncated BAG2-protein capable of inhibiting retinoic acid-induced differentiation and elucidate a mechanism through which altered gene products, relevant for neuroblastoma pathogenesis and representing possible novel drug targets, can be generated. Expand
Exome sequencing of oral squamous cell carcinoma in users of Arabian snuff reveals novel candidates for driver genes
TLDR
There was a trend for higher number of mutations, amplifications and driver events in samples with history of shammah exposure particularly those that tested EBV positive, suggesting an interaction between tobacco exposure and EBV. Expand
Altered erythropoiesis and decreased number of erythrocytes in children with neuroblastoma.
TLDR
Observations provide an alternative model to the tenet that infiltrating cells inhibit BM functions due to physical occupancy of space and may open a new area of research in NB to understand the mechanism(s) responsible for such selective impairment. Expand
Serum-circulating miRNAs predict neuroblastoma progression in mouse model of high-risk metastatic disease
TLDR
For the first time, serum-circulating miRNAs that predict the switch from favorable to HR-NB are identified and imply that these miRNAAs could play a functional role in tumor progression. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 50 REFERENCES
Origin and functional significance of large-scale chromosomal imbalances in neuroblastoma
  • R. Stallings
  • Biology, Medicine
  • Cytogenetic and Genome Research
  • 2007
TLDR
High resolution mapping of the chromosomal breakpoint regions using oligonucleotide array CGH (oaCGH) is discussed and oaCGH analysis is proving useful for both defining minimal regions of overlap of imbalances, as well as providing information on the molecular mechanisms that generate the chromosomes. Expand
Combined M‐FISH and CGH analysis allows comprehensive description of genetic alterations in neuroblastoma cell lines
TLDR
It is shown that a combination of M‐FISH with banding analysis, standard FISH, and CGH allowed a detailed description of the genetic alterations in 16 neuroblastoma cell lines and the ATBF1 gene, an AT‐binding transcription factor involved in normal neurogenesis, was shown to be present in the amplicon. Expand
Reorganization of metastamiRs in the evolution of metastatic aggressive neuroblastoma cells
TLDR
For the first time, these results identified a comprehensive list of neuroblastoma metastamiRs, related their deregulation to altered expression of protein targets, and established their association with poor clinical outcomes. Expand
Accumulation of segmental alterations determines progression in neuroblastoma.
TLDR
These data provide further evidence of the role of segmental alterations, suggesting that tumor progression is linked to the accumulation of segmentsal alterations in neuroblastoma, and should warrant biologic reinvestigation at the time of relapse. Expand
Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumors
TLDR
The NB tumors analyzed contain several interesting allelic imbalances that would either go unnoticed or be misinterpreted using other genome-wide techniques, indicating that the genetics underlying NB might be even more complex than previously known and that SNP arrays are important analysis tools. Expand
Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)
TLDR
In infants with stage 4s MYCN-non-amplifiedNB, a SCA genomic profile identifies patients who will require upfront treatment even in the absence of other clinical indication for therapy, whereas in infants with localised unresectable NB, a genomic profile characterised by the absenceof SCA identifies patients in whom treatment reduction might be possible. Expand
Oligonucleotide array‐based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcome
TLDR
High‐resolution oligonucleotide array‐based comparative genomic hybridization revealed patterns of gains and losses in neuroblastoma of particular importance since several cytogenetic markers proved to be closely associated with the clinical phenotype. Expand
Genome-Wide Analysis of Neuroblastomas using High-Density Single Nucleotide Polymorphism Arrays
TLDR
This analysis demonstrates the power of SNP arrays for high-resolution determination of LOH and DNA copy number change in neuroblastoma, a tumor in which specific allelic changes drive clinical outcome and selection of therapy. Expand
Cytogenetics and genetics of human cancer: methods and accomplishments.
TLDR
The goals of this article are to address historical and methodological aspects of cancer cytogenetics, to present information on diagnostic translocations in leukemias, lymphomas, bone and soft tissue tumors, and carcinomas, and to connect some of these chromosomal aberrations with their molecular equivalents. Expand
Genome-wide examination of chromosomal aberrations in neuroblastoma SH-SY5Y cells by array-based comparative genomic hybridization.
Most neuroblastoma cells have chromosomal aberrations such as gains, losses, amplifications and deletions of DNA. Conventional approaches like fluorescence in situ hybridization (FISH) or metaphaseExpand
...
1
2
3
4
5
...